![]() |
产地 | 中国 |
品牌 | Chemstan |
保存条件 | |
货号 | CS275096 |
用途 | 科研用途 |
应用范围 | Research Grade Biosimilar |
抗原来源 | |
保质期 | |
抗体名 | Research Grade Ebronucimab |
是否单克隆 | |
克隆性 | |
靶点 | |
适应物种 | Human |
形态 | Liquid |
宿主 | Human |
标记物 | |
包装规格 | 100ug |
亚型 | IgG1-Lambda |
标识物 | |
浓度 | 95% |
免疫原 | |
是否进口 | 否 |
Catalog No.
CS275096
Species reactivity
Human
Applications
Research Grade Biosimilar
Host species
Human
Isotype
IgG1-Lambda
Expression system
Mammalian Cells
Clonality
Monoclonal
Target
Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9
Concentration
1mg/ml
Endotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G, purified from cell culture supernatant.
Accession
Q8NBP7
Form
Liquid
Storage buffer
0.01M PBS,pH7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -679°C.
Alternate Names
AK-102,CAS:2304800-90-4
Background
Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells.
Note
For research use only. Not for use in clinical or therapeutic applications.